AtriCure, Inc. (ATRC) › Cash & EquivalentsAtriCure, Inc. (ATRC) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2008: $11.45M2009: $8.90M2010: $4.23M2011: $9.76M2012: $7.75M2013: $14.89M2014: $28.38M2015: $23.76M2016: $24.21M2017: $21.81M2018: $32.23M2019: $28.48M2020: $41.94M2021: $43.65M2022: $58.10M2023: $84.31M2024: $122.72M2025: $167.43M$167.43M2008Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$167.43M+36.4%2024$122.72M+45.6%2023$84.31M+45.1%2022$58.10M+33.1%2021$43.65M+4.1%2020$41.94M+47.3%2019$28.48M-11.6%2018$32.23M+47.8%2017$21.81M-9.9%2016$24.21M+1.9%2015$23.76M-16.3%2014$28.38M+90.6%2013$14.89M+92.1%2012$7.75M-20.6%2011$9.76M+130.7%2010$4.23M-52.5%2009$8.90M-22.2%2008$11.45M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share